Jacob Grønnegaard of FujiFilm Diosynth Biotechnologies discussed how the company’s unique cloning processes dramatically reduce project execution time, effort and expense at Emerson Exchange Immerse event. The result is intended to be one of the top medicine production facilities in the country. Hopefully, it won’t have to ramp up production for a virus vaccine to combat a worldwide pandemic, but if the time ever comes again, it will be scalable and ready.
Latest News
Emerson Ventures Invests in Symmera
Emerson today announced it has made a strategic investment through its corporate venture capital arm Emerson Ventures in Symmera, an early-stage...
Emerson Ventures Invests in First Resonance
Strategic investment from Emerson’s corporate venture capital arm supports First Resonance's ION Factory Operating System
Emerson Ventures Makes Strategic Investment in Spearix
Emerson has made a strategic investment through Emerson Ventures, its corporate venture capital arm, in Spearix Technologies, Inc., whose...
